South-Eastern Asia: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2022

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in South-Eastern Asia

In 2021, the Southeast Asian market for medicaments of alkaloids or derivatives thereof decreased by -X% to $X for the first time since 2018, thus ending a two-year rising trend. Overall, consumption, however, continues to indicate a relatively flat trend pattern. Over the period under review, the market reached the peak level at $X in 2020, and then declined slightly in the following year.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in South-Eastern Asia

In value terms, production of medicaments of alkaloids or derivatives thereof dropped to $X in 2021 estimated in export price. Over the period under review, production continues to indicate a deep slump. The pace of growth was the most pronounced in 2017 with an increase of X% against the previous year. The level of production peaked at $X in 2012; however, from 2013 to 2021, production remained at a lower figure.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports in South-Eastern Asia

In 2021, after four years of decline, there was significant growth in shipments abroad of medicaments of alkaloids or derivatives thereof, when their volume increased by X% to X tons. Over the period under review, exports, however, saw a dramatic decline. The growth pace was the most rapid in 2016 when exports increased by X%. Over the period under review, the exports of attained the maximum at X tons in 2012; however, from 2013 to 2021, the exports stood at a somewhat lower figure.

In value terms, exports of medicaments of alkaloids or derivatives thereof skyrocketed to $X in 2021. In general, exports, however, continue to indicate a precipitous curtailment. Over the period under review, the exports of hit record highs at $X in 2012; however, from 2013 to 2021, the exports failed to regain momentum.

Exports by Country

Thailand represented the largest exporting country with an export of around X tons, which finished at X% of total exports. The Philippines (X tons) held a X% share (based on physical terms) of total exports, which put it in second place, followed by Singapore (X%), Vietnam (X%), Indonesia (X%), Malaysia (X%) and Cambodia (X%).

Exports from Thailand decreased at an average annual rate of -X% from 2012 to 2021. At the same time, Indonesia (+X%) and Cambodia (+X%) displayed positive paces of growth. Moreover, Indonesia emerged as the fastest-growing exporter exported in South-Eastern Asia, with a CAGR of +X% from 2012-2021. The Philippines experienced a relatively flat trend pattern. By contrast, Vietnam (-X%), Malaysia (-X%) and Singapore (-X%) illustrated a downward trend over the same period. Thailand (+X p.p.), the Philippines (+X p.p.), Indonesia (+X p.p.), Vietnam (+X p.p.), Cambodia (+X p.p.) and Malaysia (+X p.p.) significantly strengthened its position in terms of the total exports, while Singapore saw its share reduced by -X% from 2012 to 2021, respectively.

In value terms, the largest medicaments of alkaloids or derivatives thereof supplying countries in South-Eastern Asia were the Philippines ($X), Vietnam ($X) and Singapore ($X), with a combined X% share of total exports.

The Philippines, with a CAGR of +X%, recorded the highest growth rate of the value of exports, among the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the export price in South-Eastern Asia amounted to $X per ton, declining by -X% against the previous year. In general, the export price, however, continues to indicate a temperate expansion. The most prominent rate of growth was recorded in 2020 an increase of X% against the previous year. As a result, the export price attained the peak level of $X per ton, and then reduced rapidly in the following year.

Prices varied noticeably country of origin: the country with the highest price was Vietnam ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the Philippines (+X%), while the other leaders experienced more modest paces of growth.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports in South-Eastern Asia

In 2021, approx. X tons of medicaments of alkaloids or derivatives thereof were imported in South-Eastern Asia; which is down by -X% compared with the year before. In general, imports continue to indicate a deep slump. The most prominent rate of growth was recorded in 2016 with an increase of X%. The volume of import peaked at X tons in 2013; however, from 2014 to 2021, imports stood at a somewhat lower figure.

In value terms, imports of medicaments of alkaloids or derivatives thereof rose modestly to $X in 2021. Over the period under review, imports continue to indicate a mild decline. The most prominent rate of growth was recorded in 2017 with an increase of X%. Over the period under review, imports of hit record highs at $X in 2014; however, from 2015 to 2021, imports failed to regain momentum.

Imports by Country

Malaysia was the key importer of medicaments of alkaloids or derivatives thereof in South-Eastern Asia, with the volume of imports resulting at X tons, which was approx. X% of total imports in 2021. Indonesia (X tons) took the second position in the ranking, followed by Singapore (X tons). All these countries together held approx. X% share of total imports. The following importers - Myanmar (X tons) and the Philippines (X tons) - each reached a X% share of total imports.

From 2012 to 2021, average annual rates of growth with regard to medicaments of alkaloids or derivatives thereof imports into Malaysia stood at -X%. At the same time, Singapore (+X%), Indonesia (+X%) and the Philippines (+X%) displayed positive paces of growth. Moreover, Singapore emerged as the fastest-growing importer imported in South-Eastern Asia, with a CAGR of +X% from 2012-2021. By contrast, Myanmar (-X%) illustrated a downward trend over the same period. Singapore (+X p.p.), Indonesia (+X p.p.) and the Philippines (+X p.p.) significantly strengthened its position in terms of the total imports, while Malaysia saw its share reduced by -X% from 2012 to 2021, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Malaysia ($X) constitutes the largest market for imported medicaments of alkaloids or derivatives thereof in South-Eastern Asia, comprising X% of total imports. The second position in the ranking was held by Indonesia ($X), with a X% share of total imports. It was followed by Myanmar, with a X% share.

In Malaysia, imports of medicaments of alkaloids or derivatives thereof declined by an average annual rate of -X% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Indonesia (+X% per year) and Myanmar (-X% per year).

Import Prices by Country

In 2021, the import price in South-Eastern Asia amounted to $X per ton, surging by X% against the previous year. Import price indicated a resilient increase from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, import price for medicaments of alkaloids or derivatives thereof increased by +X% against 2016 indices. The most prominent rate of growth was recorded in 2014 when the import price increased by X%. Over the period under review, import prices attained the peak figure in 2021 and is likely to see steady growth in the near future.

Prices varied noticeably country of destination: the country with the highest price was Malaysia ($X per ton), while Singapore ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Malaysia (+X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :